The impact of CYP2C9 and VKORC1 genetic polymorphism and patient characteristics upon warfarin dose requirements: proposal for a new dosing regimen

…, BP King, P Wood, P Kesteven, AK Daly, F Kamali�- Blood, 2005 - ashpublications.org
Current dosing algorithms do not account for genetic and environmental factors for warfarin
dose determinations. This study investigated the contribution of age, CYP2C9 and VKORC1 …

[HTML][HTML] A randomized trial of genotype-guided dosing of warfarin

…, AK Daly, P Avery, F Kamali…�- …�England Journal of�…, 2013 - Mass Medical Soc
Background The level of anticoagulation in response to a fixed-dose regimen of warfarin is
difficult to predict during the initiation of therapy. We prospectively compared the effect of …

Alcohol and drug use in UK university students

E Webb, CH Ashton, P Kelly, F Kamali�- The lancet, 1996 - thelancet.com
Background Alcohol and illicit drug use are increasing among school children and young
adults in the UK. Such increases have also been noted among university students and there is …

Psychological stress, anxiety, depression, job satisfaction, and personality characteristics in preregistration house officers

D Newbury-Birch, F Kamali�- Postgraduate medical journal, 2001 - academic.oup.com
Work related stress and anxiety may have a profound effect on an individual’s wellbeing. In
the case of doctors this may also affect patient care. This study measured stress, anxiety, and …

Factors influencing alcohol and illicit drug use amongst medical students

D Newbury-Birch, M White, F Kamali�- Drug and alcohol dependence, 2000 - Elsevier
Alcohol, illicit drug use, and other lifestyle variables, as well as stress, anxiety and personality
were evaluated in 194 first year medical students. 45% of the students reported drinking …

Drink and drugs: from medical students to doctors

D Newbury-Birch, D Walshaw, F Kamali�- Drug and alcohol dependence, 2001 - Elsevier
Drinking and illicit drug use were assessed longitudinally in a cohort of medical students who
were surveyed in the second and fifth year of their undergraduate studies and after 1 year …

Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarin

F Kamali, TI Khan, BP King, R Frearson…�- Clinical�…, 2004 - Wiley Online Library
Objective Our objective was to assess the contribution of CYP2C9 genotype, age, body size,
and vitamin K and lipid status to warfarin dose requirements. Methods Patients with stable …

The value of education and self‐monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation

TI Khan, F Kamali, P Kesteven, P Avery…�- British journal of�…, 2004 - Wiley Online Library
Of 125 patients aged 65 years or over, with atrial fibrillation taking warfarin for at least 12
months, with a standard deviation (SD) of prothrombin time, expressed as the International …

Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin

E Sconce, P Avery, H Wynne, F Kamali�- Blood, 2007 - ashpublications.org
Patients receiving warfarin who have unstable control of anticoagulation have a significantly
lower intake of dietary vitamin K compared with their stable counterparts. We hypothesized …

Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design

RMF Van Schie, MIA Wadelius, F Kamali…�- …, 2009 - Future Medicine
The narrow therapeutic range and wide interpatient variability in dose requirement make
anticoagulation response to coumarin derivatives unpredictable. As a result, patients require …